CHEMOALERT

Serial Number 87687685
Registration 5664435
702

Registration Progress

Application Filed
Nov 16, 2017
Under Examination
Approved for Publication
Nov 13, 2018
Published for Opposition
Nov 13, 2018
Registered
Jan 29, 2019

Basic Information

Serial Number
87687685
Registration Number
5664435
Filing Date
November 16, 2017
Registration Date
January 29, 2019
Published for Opposition
November 13, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Apr 21, 2025
Registration
Registered
Classes
009 042

Rights Holder

Bureau Veritas North America, Inc.

03
Address
1601 Sawgrass Corporate Parkway
Suite 400
Ft. Lauderdale, FL 33323

Ownership History

Bureau Veritas North America, Inc.

Original Applicant
03
Ft. Lauderdale, FL

Bureau Veritas North America, Inc.

Owner at Publication
03
Ft. Lauderdale, FL

Bureau Veritas North America, Inc.

Original Registrant
03
Ft. Lauderdale, FL

Legal Representation

Attorney
Lynn E. Rzonca
USPTO Deadlines 2 active 2 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
EXAMINER AMENDMENT
Examiner's Amendment Completed
CNEA Mar 23, 2018 2663 days overdue Low No
OPPOSITION
Notice of Publication
NPUB Dec 13, 2018 2398 days overdue Medium Until Jan 13, 2019

Application History

31 events
Date Code Type Description
Apr 21, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Apr 21, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 16, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 6, 2025 E815 I TEAS SECTION 8 & 15 RECEIVED
Jan 29, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 29, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER
Nov 13, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 13, 2018 PUBO A PUBLISHED FOR OPPOSITION
Oct 24, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 11, 2018 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 9, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 9, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 9, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 8, 2018 GNRT O NON-FINAL ACTION E-MAILED
May 8, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 8, 2018 CNRT R NON-FINAL ACTION WRITTEN
Apr 12, 2018 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 3, 2018 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 16, 2018 ALIE A ASSIGNED TO LIE
Mar 8, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 8, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED
Mar 8, 2018 GNEA O EXAMINERS AMENDMENT E-MAILED
Mar 8, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 8, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN
Mar 1, 2018 CNRT R NON-FINAL ACTION WRITTEN
Mar 1, 2018 GNRT F NON-FINAL ACTION E-MAILED
Mar 1, 2018 DOCK D ASSIGNED TO EXAMINER
Mar 1, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 29, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 20, 2017 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 009
Customized surface sampling kit for collecting chemotherapy drug residues on non-porous surfaces comprised primarily of laboratory swabs, laboratory vials and gloves for laboratory purposes, and also consisting of chemical reagents other than for medical or veterinary purpose, and a general purpose plastic bag for disposal of waste
First Use Anywhere: Oct 6, 2013
First Use in Commerce: Oct 6, 2013
Class 042
Chemical testing services, namely, testing for the presence of chemotherapy drug residues in samples from healthcare workplace surfaces to assure compliance with healthcare industry safety standards
First Use Anywhere: Oct 6, 2013
First Use in Commerce: Oct 6, 2013

Additional Information

Pseudo Mark
CHEMOTHERAPY ALERT

Classification

International Classes
009 042